Efficacy of lenalidomide for treatment of anemia in secondary myelodysplastic syndrome (MDS) with chromosome 5q deletion

被引：0
|
作者：
Mintzer, David Michael [1 ]
Billet, Shira N. [1 ]
机构：
[1] Penn Hosp, Joan Karnell Canc Ctr, Philadelphia, PA USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.4614.4614
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4614
引用
收藏
页码：226B / 226B
页数：1
相关论文
共 50 条
  • [1] Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion
    List, Alan
    Dewald, Gordon
    Bennett, John
    Giagounidis, Aristotle
    Raza, Azra
    Feldman, Eric
    Powell, Bayard
    Greenberg, Peter
    Thomas, Deborah
    Stone, Richard
    Reeder, Craig
    Wride, Kenton
    Patin, John
    Schmidt, Michele
    Zeldis, Jerome
    Knight, Robert
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1456 - 1465
  • [2] Efficacy and safety of lenalidomide in patients with myelodysplastic syndrome with chromosome 5q deletion
    Duong, Vu H.
    Komrokji, Rami S.
    List, Alan F.
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (02) : 105 - 116
  • [3] Chromosome 5q deletion in myelodysplastic syndrome
    Dwilewicz-Trojaczek, J.
    Madry, K.
    Paluszewska, M.
    Wiater, E.
    Szmigielska, A.
    Mital, A.
    Sledziowski, P.
    Salamanczuk, Z.
    Sikorska, A.
    Helbig, G.
    Wasilewska, E.
    Biedron, M.
    Calbecka, M.
    Jedrzejczak, W. W.
    [J]. LEUKEMIA RESEARCH, 2007, 31 : S91 - S91
  • [4] Azacitidine Treatment of Lenalidomide-Resistant Myelodysplastic Syndrome with Deletion 5q
    Komrokji, Rami S.
    Al Ali, Najla H.
    Padron, Eric
    Lancet, Jeffrey E.
    List, Alan F.
    [J]. BLOOD, 2011, 118 (21) : 1195 - 1195
  • [5] The role of lenalidomide in the treatment of patients with chromosome 5q deletion and other myelodysplastic syndromes
    Melchert, Magda
    Kale, Vishakha
    List, Alan
    [J]. CURRENT OPINION IN HEMATOLOGY, 2007, 14 (02) : 123 - 129
  • [6] Very short-term lenalidomide treatment associated with durable resolution of anemia in a patient with myelodysplastic syndrome with chromosome 5q deletion
    Cannella, Laura
    Latagliata, Roberto
    Breccia, Massimo
    Carmosino, Ida
    Loglisci, Giuseppina
    Volpicelli, Paola
    Ferretti, Antonietta
    Santopietro, Michelina
    Vozella, Federico
    Girmenia, Corrado
    Cuzzola, Mariella
    Oliva, Esther Natalie
    Alimena, Giuliana
    [J]. ANNALS OF HEMATOLOGY, 2012, 91 (02) : 309 - 310
  • [7] Very short-term lenalidomide treatment associated with durable resolution of anemia in a patient with myelodysplastic syndrome with chromosome 5q deletion
    Laura Cannella
    Roberto Latagliata
    Massimo Breccia
    Ida Carmosino
    Giuseppina Loglisci
    Paola Volpicelli
    Antonietta Ferretti
    Michelina Santopietro
    Federico Vozella
    Corrado Girmenia
    Mariella Cuzzola
    Esther Natalie Oliva
    Giuliana Alimena
    [J]. Annals of Hematology, 2012, 91 : 309 - 310
  • [8] Effect of lenalidomide therapy on hematopoiesis of patients with myelodysplastic syndrome associated with chromosome 5q deletion
    Ximeri, Maria
    Galanopoulos, Athanasios
    Klaus, Mirjam
    Parcharidou, Agapi
    Giannikou, Krinio
    Psyllaki, Maria
    Symeonidis, Argyrios
    Pappa, Vasiliki
    Kartasis, Zafiris
    Liapi, Dimitra
    Hatzimichael, Eleftheria
    Kokoris, Styliani
    Korkolopoulou, Penelope
    Sambani, Constantina
    Pontikoglou, Charalampos
    Papadaki, Helen A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (03): : 406 - 414
  • [9] A decade of progress in myelodysplastic syndrome with chromosome 5q deletion
    Alan List
    Benjamin L. Ebert
    Pierre Fenaux
    [J]. Leukemia, 2018, 32 : 1493 - 1499
  • [10] A decade of progress in myelodysplastic syndrome with chromosome 5q deletion
    List, Alan
    Ebert, Benjamin L.
    Fenaux, Pierre
    [J]. LEUKEMIA, 2018, 32 (07) : 1493 - 1499
12345